These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29553045)

  • 21. Metabolic Impacts of Discontinuation and Resumption of Recombinant Human Growth Hormone Treatment during the Transition Period in Patients with Childhood-Onset Growth Hormone Deficiency.
    Lee YJ; Choi Y; Yoo HW; Lee YA; Shin CH; Choi HS; Kim HS; Kim JH; Moon JE; Ko CW; Ahn MB; Suh BK; Choi JH
    Endocrinol Metab (Seoul); 2022 Apr; 37(2):359-368. PubMed ID: 35504604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study.
    Koranyi J; Svensson J; Götherström G; Sunnerhagen KS; Bengtsson B; Johannsson G
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4693-9. PubMed ID: 11600527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency.
    Biller BM; Sesmilo G; Baum HB; Hayden D; Schoenfeld D; Klibanski A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):970-6. PubMed ID: 10720025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
    Gonc EN; Kandemir N
    Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
    Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cardiovascular risk of GH-deficient adolescents.
    Colao A; Di Somma C; Salerno M; Spinelli L; Orio F; Lombardi G
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3650-5. PubMed ID: 12161490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of recombinant growth hormone (GH) treatment on bone mineral density and body composition in adults with childhood onset growth hormone deficiency.
    Sartorio A; Ortolani S; Conti A; Cherubini R; Galbiati E; Faglia G
    J Endocrinol Invest; 1996 Sep; 19(8):524-9. PubMed ID: 8905475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of recombinant human growth hormone on glucose metabolism in children with growth hormone deficiency].
    Liang L; Zou CC; Li Y; Wang CL; Jiang YJ; Dong GP; Fu JF; Wang XM
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):657-61. PubMed ID: 17217656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test.
    Aimaretti G; Baffoni C; Bellone S; Di Vito L; Corneli G; Arvat E; Benso L; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3693-9. PubMed ID: 11061526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of growth hormone status on body composition and the skeleton.
    Mukherjee A; Murray RD; Shalet SM
    Horm Res; 2004; 62 Suppl 3():35-41. PubMed ID: 15539797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
    Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy, safety and compliance of long-term growth hormone (GH) replacement therapy in adults with GH deficiency].
    Zaninelli DC; Meister LH; Radominski RB; Borba VZ; Souza AM; Boguszewski CL
    Arq Bras Endocrinol Metabol; 2008 Jul; 52(5):879-88. PubMed ID: 18797596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What happens when growth hormone is discontinued at completion of growth? Metabolic aspects.
    Johannsson G
    J Pediatr Endocrinol Metab; 2000; 13 Suppl 6():1321-6. PubMed ID: 11202204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of one year therapy with recombinant human growth hormone (rhGH) on growth velocity, calcium-phosphorus metabolism, bone mineral density and changes in body composition in children with growth hormone deficiency (GHD)].
    Zak T; Basiak A; Zubkiewicz-Kucharska A; Noczyńska A
    Pediatr Endocrinol Diabetes Metab; 2010; 16(1):39-43. PubMed ID: 20529605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term prospective study of body composition and lipid profiles during and after growth hormone (GH) treatment in children with GH deficiency: gender-specific metabolic effects.
    Kuromaru R; Kohno H; Ueyama N; Hassan HM; Honda S; Hara T
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3890-6. PubMed ID: 9814464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of growth hormone on accretion of bone mass.
    Monson JP; Drake WM; Carroll PV; Weaver JU; Rodriguez-Arnao J; Savage MO
    Horm Res; 2002; 58 Suppl 1():52-6. PubMed ID: 12373015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-sectional and prospective study of the effects of GH therapy on metabolic panel in children with GH deficiency.
    Ramistella V; Wasniewska M; Arasi S; Catena M; Velletri MR; Corica D; Santucci S; De Luca F
    Pediatr Med Chir; 2014 Dec; 36(5-6):104. PubMed ID: 25669895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic effects of discontinuing growth hormone treatment.
    Cowan FJ; Evans WD; Gregory JW
    Arch Dis Child; 1999 Jun; 80(6):517-23. PubMed ID: 10331999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial.
    Mauras N; Pescovitz OH; Allada V; Messig M; Wajnrajch MP; Lippe B;
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3946-55. PubMed ID: 15855257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.